AU2014239994B2 - Pharmaceutical soft gelatin capsule dosage form with modified guar gum - Google Patents

Pharmaceutical soft gelatin capsule dosage form with modified guar gum Download PDF

Info

Publication number
AU2014239994B2
AU2014239994B2 AU2014239994A AU2014239994A AU2014239994B2 AU 2014239994 B2 AU2014239994 B2 AU 2014239994B2 AU 2014239994 A AU2014239994 A AU 2014239994A AU 2014239994 A AU2014239994 A AU 2014239994A AU 2014239994 B2 AU2014239994 B2 AU 2014239994B2
Authority
AU
Australia
Prior art keywords
dosage form
soft gelatin
gelatin capsule
capsule dosage
fill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014239994A
Other languages
English (en)
Other versions
AU2014239994A1 (en
Inventor
Emma Karen Boyd
Ryan Gerald Loughlin
Brendan Muldoon
Gerarde SWEENEY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Therapeudics LLC
Original Assignee
Allergan Therapeudics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Therapeudics LLC filed Critical Allergan Therapeudics LLC
Publication of AU2014239994A1 publication Critical patent/AU2014239994A1/en
Assigned to ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED reassignment ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED Request for Assignment Assignors: WARNER CHILCOTT COMPANY, LLC
Priority to AU2019200116A priority Critical patent/AU2019200116A1/en
Application granted granted Critical
Publication of AU2014239994B2 publication Critical patent/AU2014239994B2/en
Assigned to Allergan Therapeutics LLC reassignment Allergan Therapeutics LLC Request for Assignment Assignors: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2014239994A 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum Active AU2014239994B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2019200116A AU2019200116A1 (en) 2013-03-15 2019-01-09 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794906P 2013-03-15 2013-03-15
US61/794,906 2013-03-15
PCT/US2014/027145 WO2014152269A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019200116A Division AU2019200116A1 (en) 2013-03-15 2019-01-09 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Publications (2)

Publication Number Publication Date
AU2014239994A1 AU2014239994A1 (en) 2015-10-08
AU2014239994B2 true AU2014239994B2 (en) 2019-01-24

Family

ID=50588879

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2014239994A Active AU2014239994B2 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum
AU2019200116A Abandoned AU2019200116A1 (en) 2013-03-15 2019-01-09 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2019200116A Abandoned AU2019200116A1 (en) 2013-03-15 2019-01-09 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Country Status (14)

Country Link
US (3) US9795569B2 (cg-RX-API-DMAC7.html)
EP (2) EP2950781B1 (cg-RX-API-DMAC7.html)
JP (3) JP6335270B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150131070A (cg-RX-API-DMAC7.html)
CN (2) CN105307634B (cg-RX-API-DMAC7.html)
AU (2) AU2014239994B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015022946A8 (cg-RX-API-DMAC7.html)
CA (1) CA2906633C (cg-RX-API-DMAC7.html)
ES (1) ES2619121T3 (cg-RX-API-DMAC7.html)
HK (1) HK1218622A1 (cg-RX-API-DMAC7.html)
IL (1) IL241377B (cg-RX-API-DMAC7.html)
MX (2) MX364440B (cg-RX-API-DMAC7.html)
RU (1) RU2676480C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014152269A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2950781B1 (en) * 2013-03-15 2016-12-21 Warner Chilcott Company, LLC Pharmaceutical soft gelatin capsule dosage form with modified guar gum
CA2980165C (en) 2015-03-26 2021-06-15 Patheon Softgels Inc. Liquisoft capsules
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
CN116916895A (zh) * 2020-11-13 2023-10-20 辉瑞公司 他拉唑帕尼软明胶胶囊剂型
MX2023005641A (es) * 2020-11-13 2023-05-24 Pfizer Forma de dosificacion en capsula de gelatina blanda de talazoparib.
CN116531444B (zh) * 2023-07-06 2023-10-10 健码制药（广东）有限公司 镇咳清肺软胶囊及其制备工艺

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070098783A1 (en) * 2005-10-26 2007-05-03 Banner Pharmacaps, Inc. Hydrophilic Vehicle-Based Dual Controlled Release Matrix System

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
FR2739558B1 (fr) 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
IT1275816B1 (it) 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
AU1925697A (en) 1996-03-12 1997-10-01 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5989535A (en) 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (cg-RX-API-DMAC7.html) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
FR2843304B1 (fr) * 2002-08-07 2005-12-16 Ricarimpex Extraits de sangsues pour stents
US20070066837A1 (en) 2003-02-18 2007-03-22 Ahmed Kamal Podophyllotoxin derivatives as antitumor agents
KR100570450B1 (ko) * 2003-09-25 2006-04-12 한국유나이티드제약 주식회사 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US7067504B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
US7067505B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
CA2612380C (en) 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
MX2008000412A (es) 2005-07-12 2008-03-10 Warner Chilcott Co Inc Profarmacos de 3-ester de estradiol.
WO2007024338A2 (en) 2005-07-12 2007-03-01 Warner Chilcott Company, Inc. 3 -ester prodrugs of ethynylestradiol
US7468970B2 (en) 2005-10-24 2008-12-23 Honeywell International Inc. Routing of mobile agents in a network
WO2007056424A2 (en) 2005-11-07 2007-05-18 Penwest Pharmaceuticals, Co. Controlled-release emulsion compositions
WO2007066837A1 (en) 2005-12-06 2007-06-14 Lg Household & Health Care Ltd. Delivery system for tooth whitening component using in situ gelling
WO2007091856A1 (en) 2006-02-10 2007-08-16 Lg Household & Health Care Ltd. In-situ melting and gelling tablet composition for oral care
US20080090569A1 (en) 2006-10-13 2008-04-17 At&T Knowledge Ventures, L.P. Method and apparatus for performing signal processing in an ip multimedia subsystem network
US20080122993A1 (en) 2006-11-29 2008-05-29 Sanyo Electric Co., Ltd. Television image receiver
JP2010532746A (ja) 2007-01-25 2010-10-14 パナセア バイオテック リミテッド 放出調節医薬組成物およびその製造方法
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles
JP2011518367A (ja) 2008-03-26 2011-06-23 クルーシャル テック カンパニー リミテッド 光ポインティング装置及びこれを備える携帯電子機器
CN101474167A (zh) * 2009-01-23 2009-07-08 西安德天药业股份有限公司 雌二醇阴道用胶囊的制备方法
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
EP2950781B1 (en) * 2013-03-15 2016-12-21 Warner Chilcott Company, LLC Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070098783A1 (en) * 2005-10-26 2007-05-03 Banner Pharmacaps, Inc. Hydrophilic Vehicle-Based Dual Controlled Release Matrix System

Also Published As

Publication number Publication date
EP2950781B1 (en) 2016-12-21
IL241377B (en) 2019-08-29
CN105307634B (zh) 2020-03-10
CN111374959A (zh) 2020-07-07
US20150044285A1 (en) 2015-02-12
US10744096B2 (en) 2020-08-18
IL241377A0 (en) 2015-11-30
JP2018140998A (ja) 2018-09-13
WO2014152269A1 (en) 2014-09-25
US9795569B2 (en) 2017-10-24
JP2016513684A (ja) 2016-05-16
AU2019200116A1 (en) 2019-01-31
HK1218622A1 (zh) 2017-03-03
EP3187170A1 (en) 2017-07-05
RU2676480C2 (ru) 2018-12-29
KR20150131070A (ko) 2015-11-24
NZ712280A (en) 2021-01-29
MX364440B (es) 2019-04-26
US9820946B2 (en) 2017-11-21
RU2015137612A (ru) 2017-04-24
US20180036252A1 (en) 2018-02-08
JP6704430B2 (ja) 2020-06-03
CA2906633A1 (en) 2014-09-25
AU2014239994A1 (en) 2015-10-08
CA2906633C (en) 2021-11-30
BR112015022946A8 (pt) 2022-11-29
BR112015022946A2 (pt) 2017-07-18
US20140271838A1 (en) 2014-09-18
MX2019004554A (es) 2019-08-05
MX2015012057A (es) 2016-05-05
CN105307634A (zh) 2016-02-03
ES2619121T3 (es) 2017-06-23
JP6335270B2 (ja) 2018-05-30
EP2950781A1 (en) 2015-12-09
JP2020147569A (ja) 2020-09-17

Similar Documents

Publication Publication Date Title
US10744096B2 (en) Pharmaceutical soft gelatin capsule dosage form with modified guar gum
BRPI0713565B1 (pt) processo para fabricação de uma forma de dosagem oral sólida
BR112014031914B1 (pt) Formulação farmacêutica encapsulada para liberação intravaginal compreendendo estradiol e uso da mesma para o tratamento de atrofia vulvovaginal e de um sistoma associado, bem como de um estado urinário deficiente em estrogênio
WO2010117873A2 (en) Progesterone solutions for increased bioavailability
JP2003508441A (ja) 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
JP6335269B2 (ja) 医薬ソフトゼラチンカプセル剤形
JP2016514692A (ja) チキソトロピーならびに強化された溶解再現性及び安定性を有する組成物
AU2010328375B2 (en) 4-methylpyrazole formulations
NZ712280B2 (en) Pharmaceutical soft gelatin capsule dosage form with modified guar gum
KR20160137597A (ko) 프로게스테론 제형

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED

Free format text: FORMER APPLICANT(S): WARNER CHILCOTT COMPANY, LLC

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: ALLERGAN THERAPEUTICS LLC

Free format text: FORMER OWNER(S): ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED